Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Orchid Pharma Ltd.
₹665
₹655.00
₹677.40
₹603.80
₹1062.95
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 207.27 | 193.52 | 172.93 | 237.48 | 217.34 |
| Operating Expense | 204.43 | 194.19 | 158.75 | 203.15 | 190.98 |
| Operating Profit | 2.84 | -0.67 | 14.18 | 34.33 | 26.36 |
| Depreciation | 8.97 | 8.79 | 8.65 | 8.76 | 8.60 |
| Interest | 3.17 | 3.73 | 3.26 | 3.98 | 3.79 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -5.82 | 2.23 | 18.20 | 27.85 | 23.91 |
₹665.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 |
| FII | 1.9 | 2.5 | 2.7 | 1.4 | 1.6 | 1.2 |
| DII | 18.3 | 19 | 20.1 | 19.4 | 19 | 19.4 |
| Public | 9.9 | 8.6 | 7.4 | 9.3 | 9.6 | 9.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 26.32 K | 42.78 K | 61.52% |
| Week | 24.11 K | 38.64 K | 62.41% |
| 1 Month | 34.7 K | 51.79 K | 67.00% |
| 6 Month | 46.36 K | 97.55 K | 47.52% |
Benjamin Graham Value Screen
Expensive Performers (DVM)
PEG lower than Industry PEG
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 13 Sep, 2012 | 3 | FINAL | Equity Share | |
| 19 Jul, 2011 | 3 | FINAL | Equity Share | |
| 12 Jul, 2010 | 10 | FINAL | Equity Share | |
| 17 Sep, 2009 | 1 | FINAL | Equity Share | |
| 18 Sep, 2008 | 3 | FINAL | Equity Share | |
| 12 Jul, 2007 | 3 | FINAL | Equity Share | |
| 30 May, 2006 | 3 | FINAL | Equity Share | |
| 13 Jul, 2005 | 4 | FINAL | Equity Share | |
| 15 Jul, 2004 | 4 | FINAL | Equity Share | |
| 17 Jul, 2003 | 4 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹8.43 | ₹104 | ₹115.35 | ₹604 | ₹791.10 | ₹690 |
| % Change | 4.98% | -1.38% | -3.98% | -1.99% | -2.37% | 3.06% |
| Revenue TTM (₹ Cr) | ₹104.12 | ₹282.74 | - | ₹488.20 | ₹588.52 | ₹1,496.96 |
| Net Profit TTM (₹ Cr) | ₹-24.37 | ₹15.30 | - | ₹56.90 | ₹101.60 | ₹132.41 |
| PE TTM | -2.90 | 26.50 | - | 30.70 | 36.00 | 29.60 |
| 1 Year Return | 743 | -17.19 | 27.77 | 0.89 | 41.16 | -12.8 |
| ROCE | -5.63 | - | - | 23.87 | 9.34 | 14.12 |
Valiant Laboratories Ltd.
₹ 59.10
+1.37%
Sigachi Industries Ltd.
₹ 21.22
-3.68%
Windlas Biotech Ltd.
₹ 774.00
-0.82%
Vineet Laboratories Ltd.
₹ 31.51
-1.62%
Solara Active Pharma Sciences Ltd.
₹ 472.60
+0.23%
Zim Laboratories Ltd.
₹ 72.00
+1.72%
Medico Remedies Ltd.
₹ 48.00
+4.53%
Dishman Carbogen Amcis Ltd.
₹ 182.40
+0.07%
Lasa Supergenerics Ltd.
₹ 8.05
+2.42%
Advanced Enzyme Technologies Ltd.
₹ 313.00
+0.02%
Bajaj Healthcare Ltd.
₹ 348.00
-1.29%
Ortin Global Ltd.
₹ 18.91
-4.97%
Brooks Laboratories Ltd.
₹ 72.62
-2.48%
RPG Life Sciences Ltd.
₹ 1915.00
+0.59%
Bafna Pharmaceuticals Ltd.
₹ 111.50
-1.11%
Alpa Laboratories Ltd.
₹ 68.45
+2.30%
Sun Pharma Advanced Research Company Ltd.
₹ 127.75
-1.13%
SMS Pharmaceuticals Ltd.
₹ 375.20
+0.74%
Nectar Lifesciences Ltd.
₹ 12.70
+0.63%
Mangalam Drugs and Organics Ltd.
₹ 31.15
-1.61%
Indoco Remedies Ltd.
₹ 200.10
+0.93%
Ind-Swift Laboratories Ltd.
₹ 146.60
+3.32%
Lincoln Pharmaceuticals Ltd.
₹ 619.00
-0.58%
Panacea Biotec Ltd.
₹ 338.80
-0.79%
By signing up I certify terms, conditions & privacy policy